ACTA1 and neoplasm: Protein-level analyses showed decreased endothelial markers (claudin-5, VE-cadherin) and increased mesenchymal markers (fibronectin, α-SMA), accompanied by reduced transendothelial electrical resistance (TEER) and enhanced tumor–cell adhesion and transmigration.